Sansheng Guo Jian, founded in 2002, is the first batch of innovative biomedical enterprises focusing on antibody drugs in China. It is also a pharmaceutical company with three therapeutic antibody drugs listed in China, and has developed into a pioneer of antibody drugs with independent research and development, industrialization and commercialization capabilities in China.
The company has the national antibody drug engineering research center and the leading antibody drug production base among domestic biopharmaceutical companies. The total scale of bioreactor has exceeded 40,000 liters. The company takes innovative therapeutic antibody drugs as its main research and development direction, and provides high-quality, safe and effective clinical solutions for the treatment of autoimmune diseases, tumors and other major diseases.
Sansheng Guo Jian adheres to the concept of "cherishing life, paying attention to survival and creating life", devotes itself to becoming an innovative therapeutic antibody drug company that benefits China and faces the world, practices the corporate mission of "making innovative antibody drugs within reach", continuously enhances people's sense of acquisition, happiness and security, and contributes to the construction of healthy China.